Back to search

France· FR:60368099

ONCOVIN 1 mg, solution injectable

A vincristine product containing sulfate de vincristine, registered in France by EG LABO - LABORATOIRES EUROGENERICS, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC L01CA02

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedONCOVIN 1 mg, solution injectableATCL01CA02REGISTER NO.FR:60368099PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Vincristine is registered in 16 of 19 countries.

Countries holding a registration under ATC L01CA02 (vincristine), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 9 of them publish a price we can compare per daily dose

Vincristine · ATC L01CA02

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
SULFATE DE VINCRISTINE
Manufacturer
EG LABO - LABORATOIRES EUROGENERICS
Country
France (FR)
ATC code
L01CA02
ATC class
Vincristine
Defined daily dose
0.36 mg, P
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400932649983
    1 flacon(s) en verre de 1 ml
    EUR 11.38

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

583 interactions on record for vincristine.

Graded by severity as the source publishes them — 63 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Vincristine · interactions on record

583 records

  • 63 severe
  • 282 moderate
  • 25 minor
  • 213 info

Most severe, free to view

  • LonafarnibA16AX20severe
  • ConivaptanC03XA02severe
  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Vincristine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All vincristine products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

  • Austria · Oncovin, Vincristin Pfizer
  • Belgium · Vincrisin
  • Czechia · Vincristine Teva
  • Germany · Cellcristin, Vincristinsulfat Teva
  • Denmark · Oncovin
  • Spain · Vincristina Pfizer
  • Finland · Oncovin
  • United Kingdom (Northern Ireland) · Vincristine Sulfate Hospira Uk, Vincristine Sulfate Teva Uk
  • Ireland · Vincristine Sulfate Pfizer Healthcare Ireland
  • Italy · Vincristina, Vincristina Pfizer Italia
  • Lithuania · Vincristine Teva
  • Luxembourg · Vincrisin
  • Latvia · Vincristine Teva
  • Netherlands · Vincristinesulfaat Teva
  • Norway · Vincristine Pfizer
  • Poland · Vincristine Teva
  • Portugal · Vincristina Teva
  • Romania · Sindovin, Vincristină Teva
  • Sweden · Oncovin, Vincristine Pfizer

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/36ecd474-52b7-4bfe-a2ac-ab4ff42e0a46
GET /v1/drugs/36ecd474-52b7-4bfe-a2ac-ab4ff42e0a46?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "60368099",
  "date_amm": "1997-12-23",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "SULFATE DE VINCRISTINE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution injectable",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about vincristine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.